Brian Reemtsen
Concepts (219)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiac Surgical Procedures | 10 | 2017 | 318 | 2.360 |
Why?
| Extracellular Matrix | 3 | 2017 | 111 | 1.660 |
Why?
| Heart Defects, Congenital | 12 | 2020 | 608 | 1.510 |
Why?
| Heart Ventricles | 7 | 2020 | 271 | 1.350 |
Why?
| Postoperative Complications | 5 | 2019 | 1035 | 0.770 |
Why?
| Ebstein Anomaly | 3 | 2008 | 7 | 0.690 |
Why?
| Vascular Grafting | 1 | 2018 | 6 | 0.640 |
Why?
| Blalock-Taussig Procedure | 1 | 2018 | 21 | 0.630 |
Why?
| Anticoagulants | 2 | 2018 | 270 | 0.620 |
Why?
| Blood Vessel Prosthesis | 2 | 2018 | 97 | 0.620 |
Why?
| Heparin | 1 | 2018 | 97 | 0.600 |
Why?
| Heart Valve Prosthesis Implantation | 4 | 2018 | 92 | 0.570 |
Why?
| Infant | 15 | 2020 | 3832 | 0.570 |
Why?
| Mitral Valve Insufficiency | 1 | 2017 | 63 | 0.560 |
Why?
| Foreign-Body Reaction | 1 | 2015 | 6 | 0.540 |
Why?
| Heart Septum | 1 | 2015 | 24 | 0.530 |
Why?
| Heart Valves | 1 | 2015 | 15 | 0.530 |
Why?
| Calcinosis | 1 | 2015 | 61 | 0.520 |
Why?
| Tetralogy of Fallot | 3 | 2020 | 94 | 0.470 |
Why?
| Intestinal Mucosa | 1 | 2015 | 259 | 0.470 |
Why?
| Prosthesis Implantation | 2 | 2014 | 47 | 0.430 |
Why?
| Inflammation | 1 | 2015 | 679 | 0.380 |
Why?
| Treatment Outcome | 14 | 2018 | 5609 | 0.380 |
Why?
| Retrospective Studies | 13 | 2020 | 6462 | 0.370 |
Why?
| Cardiopulmonary Bypass | 4 | 2015 | 97 | 0.350 |
Why?
| Cor Triatriatum | 1 | 2008 | 2 | 0.340 |
Why?
| Survival Rate | 5 | 2019 | 954 | 0.340 |
Why?
| Pulmonary Valve | 3 | 2018 | 42 | 0.330 |
Why?
| Vena Cava, Inferior | 2 | 2008 | 79 | 0.330 |
Why?
| Child, Preschool | 12 | 2019 | 4161 | 0.330 |
Why?
| Heart Septal Defects, Atrial | 1 | 2008 | 45 | 0.330 |
Why?
| Male | 25 | 2020 | 27335 | 0.330 |
Why?
| Funnel Chest | 1 | 2008 | 8 | 0.330 |
Why?
| Female | 22 | 2020 | 28457 | 0.320 |
Why?
| Cardiac Catheterization | 4 | 2018 | 259 | 0.310 |
Why?
| Transcriptome | 3 | 2020 | 346 | 0.310 |
Why?
| Infant, Newborn | 7 | 2019 | 2923 | 0.290 |
Why?
| Follow-Up Studies | 5 | 2017 | 2389 | 0.280 |
Why?
| Humans | 31 | 2020 | 54304 | 0.280 |
Why?
| Palliative Care | 2 | 2010 | 188 | 0.280 |
Why?
| Los Angeles | 5 | 2017 | 25 | 0.270 |
Why?
| Hypoplastic Left Heart Syndrome | 1 | 2007 | 97 | 0.270 |
Why?
| Heart Transplantation | 3 | 2017 | 307 | 0.260 |
Why?
| Heart | 2 | 2017 | 361 | 0.250 |
Why?
| Echocardiography | 2 | 2017 | 392 | 0.240 |
Why?
| Tricuspid Valve Insufficiency | 2 | 2018 | 16 | 0.240 |
Why?
| Peptide Fragments | 2 | 2015 | 242 | 0.240 |
Why?
| Heart-Assist Devices | 2 | 2017 | 147 | 0.230 |
Why?
| Adolescent | 10 | 2018 | 6896 | 0.220 |
Why?
| Thrombosis | 2 | 2017 | 243 | 0.220 |
Why?
| Child | 11 | 2020 | 7372 | 0.210 |
Why?
| Reoperation | 2 | 2017 | 453 | 0.200 |
Why?
| Magnetic Resonance Imaging | 3 | 2017 | 1616 | 0.190 |
Why?
| Wnt Proteins | 2 | 2019 | 110 | 0.190 |
Why?
| DiGeorge Syndrome | 1 | 2020 | 20 | 0.190 |
Why?
| Heart Valve Prosthesis | 2 | 2018 | 93 | 0.180 |
Why?
| Polytetrafluoroethylene | 2 | 2018 | 36 | 0.180 |
Why?
| Perfusion | 1 | 2019 | 41 | 0.170 |
Why?
| Cardiac Valve Annuloplasty | 1 | 2018 | 2 | 0.170 |
Why?
| Thymus Gland | 1 | 1999 | 45 | 0.170 |
Why?
| Immune System | 1 | 1999 | 48 | 0.170 |
Why?
| Time Factors | 5 | 2017 | 3207 | 0.170 |
Why?
| Immune Tolerance | 1 | 1999 | 105 | 0.170 |
Why?
| Tricuspid Valve | 1 | 2018 | 24 | 0.170 |
Why?
| Graft Survival | 2 | 2017 | 165 | 0.160 |
Why?
| Norwood Procedures | 1 | 2019 | 57 | 0.160 |
Why?
| Pulmonary Valve Insufficiency | 1 | 2018 | 20 | 0.160 |
Why?
| Gene Expression Profiling | 3 | 2020 | 1141 | 0.160 |
Why?
| Contrast Media | 2 | 2017 | 221 | 0.160 |
Why?
| Cerebrovascular Circulation | 1 | 2019 | 137 | 0.160 |
Why?
| Transplants | 1 | 2018 | 18 | 0.160 |
Why?
| Tachycardia, Ventricular | 1 | 2018 | 43 | 0.160 |
Why?
| Hemorrhage | 2 | 2017 | 209 | 0.150 |
Why?
| Heart Septal Defects | 1 | 2017 | 12 | 0.150 |
Why?
| California | 1 | 2017 | 90 | 0.150 |
Why?
| Endocarditis | 1 | 2017 | 33 | 0.150 |
Why?
| Cell Proliferation | 2 | 2020 | 1097 | 0.150 |
Why?
| Critical Illness | 1 | 2020 | 343 | 0.150 |
Why?
| Physicians | 1 | 2020 | 244 | 0.140 |
Why?
| Off-Label Use | 1 | 2016 | 27 | 0.140 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2017 | 119 | 0.140 |
Why?
| Fibroblast Growth Factors | 1 | 2015 | 60 | 0.130 |
Why?
| Necrosis | 1 | 2015 | 208 | 0.130 |
Why?
| Fibrosis | 1 | 2015 | 209 | 0.130 |
Why?
| Heart, Artificial | 1 | 2014 | 2 | 0.130 |
Why?
| Hirudins | 1 | 2014 | 16 | 0.120 |
Why?
| Premedication | 1 | 2014 | 18 | 0.120 |
Why?
| Myocardium | 1 | 2016 | 443 | 0.120 |
Why?
| Animals, Newborn | 3 | 2020 | 396 | 0.110 |
Why?
| Databases, Factual | 1 | 2015 | 683 | 0.110 |
Why?
| Echocardiography, Transesophageal | 2 | 2008 | 73 | 0.100 |
Why?
| Heart Failure | 1 | 2017 | 541 | 0.100 |
Why?
| Severity of Illness Index | 2 | 2018 | 1083 | 0.100 |
Why?
| Acute Kidney Injury | 1 | 2015 | 404 | 0.100 |
Why?
| Pulmonary Circulation | 2 | 2007 | 36 | 0.090 |
Why?
| Risk Factors | 5 | 2019 | 3934 | 0.090 |
Why?
| Anastomosis, Surgical | 2 | 2007 | 72 | 0.090 |
Why?
| Tachycardia, Supraventricular | 1 | 2010 | 39 | 0.090 |
Why?
| Fontan Procedure | 1 | 2010 | 56 | 0.090 |
Why?
| Epithelial-Mesenchymal Transition | 2 | 2020 | 53 | 0.090 |
Why?
| Risk Assessment | 3 | 2010 | 1361 | 0.090 |
Why?
| Failure to Thrive | 1 | 2008 | 21 | 0.080 |
Why?
| Catheter Ablation | 1 | 2010 | 131 | 0.080 |
Why?
| Mice, Inbred C57BL | 3 | 2020 | 2002 | 0.080 |
Why?
| Thoracoscopy | 1 | 2008 | 20 | 0.080 |
Why?
| Venous Pressure | 1 | 2008 | 20 | 0.080 |
Why?
| Lung Transplantation | 1 | 2008 | 27 | 0.080 |
Why?
| Coronary Thrombosis | 1 | 2008 | 26 | 0.080 |
Why?
| Respiratory Paralysis | 1 | 2007 | 5 | 0.080 |
Why?
| Coronary Aneurysm | 1 | 2008 | 21 | 0.080 |
Why?
| Constriction, Pathologic | 1 | 2008 | 104 | 0.080 |
Why?
| Pneumothorax | 1 | 2008 | 22 | 0.080 |
Why?
| Pericardium | 1 | 2008 | 29 | 0.080 |
Why?
| Mucocutaneous Lymph Node Syndrome | 1 | 2008 | 23 | 0.080 |
Why?
| Phlebography | 1 | 2008 | 70 | 0.080 |
Why?
| Bronchoscopy | 1 | 2008 | 79 | 0.080 |
Why?
| Diaphragm | 1 | 2007 | 29 | 0.080 |
Why?
| Signal Transduction | 3 | 2020 | 1751 | 0.080 |
Why?
| Biopsy, Needle | 1 | 2008 | 195 | 0.080 |
Why?
| Prosthesis Failure | 1 | 2008 | 113 | 0.080 |
Why?
| Bioprosthesis | 2 | 2018 | 32 | 0.080 |
Why?
| Device Removal | 1 | 2008 | 97 | 0.080 |
Why?
| Cohort Studies | 3 | 2019 | 1547 | 0.080 |
Why?
| Graft Rejection | 1 | 2008 | 161 | 0.080 |
Why?
| Hypotension | 1 | 2008 | 67 | 0.080 |
Why?
| Gene Regulatory Networks | 2 | 2019 | 124 | 0.080 |
Why?
| Blood Circulation | 1 | 2007 | 20 | 0.070 |
Why?
| Organ Size | 1 | 2007 | 237 | 0.070 |
Why?
| Abnormalities, Multiple | 1 | 2008 | 162 | 0.070 |
Why?
| Scimitar Syndrome | 1 | 2007 | 8 | 0.070 |
Why?
| Heart Atria | 1 | 2007 | 57 | 0.070 |
Why?
| Pulmonary Veins | 1 | 2007 | 31 | 0.070 |
Why?
| Ventricular Dysfunction, Right | 1 | 2007 | 32 | 0.070 |
Why?
| Infant, Low Birth Weight | 1 | 2007 | 76 | 0.070 |
Why?
| Prosthesis Design | 2 | 2018 | 262 | 0.070 |
Why?
| Vascular Surgical Procedures | 1 | 2008 | 178 | 0.070 |
Why?
| Young Adult | 4 | 2018 | 4313 | 0.070 |
Why?
| Adult | 7 | 2018 | 14189 | 0.070 |
Why?
| Pulmonary Artery | 1 | 2007 | 152 | 0.070 |
Why?
| Ultrasonography | 1 | 2007 | 486 | 0.070 |
Why?
| Incidence | 2 | 2019 | 1083 | 0.060 |
Why?
| Transplantation, Homologous | 2 | 2008 | 154 | 0.060 |
Why?
| Proportional Hazards Models | 2 | 2018 | 430 | 0.060 |
Why?
| Infant, Premature | 1 | 2007 | 337 | 0.060 |
Why?
| Predictive Value of Tests | 2 | 2017 | 1044 | 0.060 |
Why?
| Recovery of Function | 2 | 2018 | 222 | 0.060 |
Why?
| Hospital Mortality | 2 | 2019 | 466 | 0.050 |
Why?
| Animals | 4 | 2020 | 14402 | 0.050 |
Why?
| Prognosis | 2 | 2018 | 2126 | 0.050 |
Why?
| Prospective Studies | 2 | 2019 | 2604 | 0.050 |
Why?
| Gastrostomy | 1 | 2020 | 60 | 0.050 |
Why?
| E2F1 Transcription Factor | 1 | 2019 | 8 | 0.050 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2019 | 34 | 0.050 |
Why?
| Transplantation Immunology | 1 | 1999 | 6 | 0.040 |
Why?
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2019 | 5 | 0.040 |
Why?
| Tracheostomy | 1 | 2020 | 81 | 0.040 |
Why?
| Rats, Inbred Strains | 1 | 1999 | 172 | 0.040 |
Why?
| Th2 Cells | 1 | 1999 | 26 | 0.040 |
Why?
| Genome | 1 | 2019 | 74 | 0.040 |
Why?
| Isoantibodies | 1 | 1999 | 31 | 0.040 |
Why?
| Antibody Formation | 1 | 1999 | 69 | 0.040 |
Why?
| Th1 Cells | 1 | 1999 | 50 | 0.040 |
Why?
| Poisson Distribution | 1 | 2018 | 32 | 0.040 |
Why?
| Echocardiography, Doppler | 1 | 2018 | 61 | 0.040 |
Why?
| Genes, cdc | 1 | 2017 | 6 | 0.040 |
Why?
| Retinoblastoma Protein | 1 | 2017 | 22 | 0.040 |
Why?
| Critical Care | 1 | 2020 | 234 | 0.040 |
Why?
| Mice | 2 | 2020 | 6428 | 0.040 |
Why?
| Propensity Score | 1 | 2018 | 137 | 0.040 |
Why?
| Kinetics | 1 | 1999 | 692 | 0.040 |
Why?
| Hemodynamics | 1 | 2018 | 291 | 0.040 |
Why?
| Autopsy | 1 | 2017 | 52 | 0.040 |
Why?
| Delivery of Health Care | 1 | 2020 | 325 | 0.040 |
Why?
| Echocardiography, Doppler, Color | 1 | 2016 | 30 | 0.040 |
Why?
| Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2016 | 2 | 0.040 |
Why?
| Myoblasts, Cardiac | 1 | 2016 | 3 | 0.040 |
Why?
| Observer Variation | 1 | 2017 | 139 | 0.040 |
Why?
| Multivariate Analysis | 1 | 2018 | 643 | 0.040 |
Why?
| Age Distribution | 1 | 2016 | 198 | 0.030 |
Why?
| Down-Regulation | 1 | 2017 | 388 | 0.030 |
Why?
| Middle Aged | 3 | 2018 | 13076 | 0.030 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2016 | 151 | 0.030 |
Why?
| Cytokines | 1 | 1999 | 677 | 0.030 |
Why?
| Phosphorylation | 1 | 2017 | 613 | 0.030 |
Why?
| Patient Safety | 1 | 2016 | 121 | 0.030 |
Why?
| Coronary Angiography | 1 | 2017 | 411 | 0.030 |
Why?
| Gene Expression | 1 | 2017 | 664 | 0.030 |
Why?
| Cross-Sectional Studies | 1 | 2020 | 1693 | 0.030 |
Why?
| Gene Expression Regulation | 1 | 2019 | 1064 | 0.030 |
Why?
| Antithrombins | 1 | 2014 | 21 | 0.030 |
Why?
| Compassionate Use Trials | 1 | 2013 | 7 | 0.030 |
Why?
| Hyperbilirubinemia | 1 | 2013 | 13 | 0.030 |
Why?
| Body Size | 1 | 2013 | 30 | 0.030 |
Why?
| Waiting Lists | 1 | 2013 | 49 | 0.030 |
Why?
| Reproducibility of Results | 1 | 2017 | 1294 | 0.030 |
Why?
| Multiple Organ Failure | 1 | 2013 | 56 | 0.030 |
Why?
| Chronic Disease | 1 | 2015 | 614 | 0.030 |
Why?
| RNA, Messenger | 1 | 2016 | 1203 | 0.030 |
Why?
| Mortality | 1 | 2013 | 102 | 0.030 |
Why?
| Recombinant Proteins | 1 | 2014 | 570 | 0.030 |
Why?
| Cells, Cultured | 1 | 2016 | 1737 | 0.030 |
Why?
| Liver Diseases | 1 | 2013 | 87 | 0.030 |
Why?
| Rats | 1 | 1999 | 3417 | 0.030 |
Why?
| Cause of Death | 1 | 2013 | 164 | 0.030 |
Why?
| Risk | 1 | 2013 | 343 | 0.030 |
Why?
| Equipment Design | 1 | 2013 | 318 | 0.030 |
Why?
| Comorbidity | 1 | 2013 | 666 | 0.020 |
Why?
| Heart Diseases | 1 | 2013 | 239 | 0.020 |
Why?
| Kidney Diseases | 1 | 2013 | 293 | 0.020 |
Why?
| Extracorporeal Membrane Oxygenation | 1 | 2013 | 302 | 0.020 |
Why?
| Recurrence | 1 | 2010 | 692 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2016 | 3430 | 0.020 |
Why?
| Phrenic Nerve | 1 | 2007 | 5 | 0.020 |
Why?
| United States | 1 | 2019 | 5204 | 0.020 |
Why?
| Monitoring, Physiologic | 1 | 2008 | 136 | 0.020 |
Why?
| Stroke | 1 | 2013 | 526 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2008 | 922 | 0.020 |
Why?
| Immunohistochemistry | 1 | 2008 | 1090 | 0.020 |
Why?
| Aged | 1 | 2016 | 10054 | 0.010 |
Why?
|
|
Reemtsen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Same Department
People who are also in this person's primary department.
|